Epidemiological Data on Melanoma from the Referral Centre in Croatia (2002–2007) by Marija Buljan et al.
Coll. Antropol. 32 (2008) Suppl. 2: 47–51
Original scientific paper
Epidemiological Data on Melanoma from the
Referral Centre in Croatia (2002–2007)
Marija Buljan1, Nada Raja~i}1, Maja Vurnek @ivkovi}1, Iva Blaji}1, Zvonko Kusi}2 and Mirna [itum1
1 Department of Dermatology and Venereology, University Hospital »Sestre milosrdnice«, Zagreb, Croatia
2 Department of Nuclear Medicine and Oncology, University Hospital »Sestre milosrdnice«, Zagreb, Croatia
A B S T R A C T
Melanoma is considered to be one of the most aggressive skin tumors. Various studies have shown that the incidence
rate for this malignancy is rising rapidly all over the world. Incidence rates vary substantially worldwide with New Zea-
land and Australia having the highest rates. In the past 40 years in Croatia the incidence of melanoma is also in rise for
more than 300%. Women and men are almost equally affected. According to anatomical site in most populations the rise
is the greatest for the male trunk, and extremities in both sexes. There has been little change in rates for the head and
neck. In the last decades, melanoma often occurs in relatively younger people, between the age of 25 and 40, rarely in the
childhood. However, survival in patients with melanoma in Western European countries has increased markedly in re-
cent years, due to timely recognition of the disease. Unfortunately, in Croatia the mortality remains higher even though
the incidence is lower than those in some Western European countries. The authors are presenting epidemiological data
on melanoma during the last 6 years (for the period 2002–2007) from the Croatian Referral Centre for Melanoma which
is placed in the University Hospital »Sestre milosrdnice« in Zagreb.
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Introduction
Melanoma is one of the most aggressive malignant tu-
mors of the skin and its frequency is in constant rise in
the last decades; with the increase higher than other ma-
lignant skin tumors. Melanoma incidence is increasing
from 3 to 8% per year in different regions of the world; in
Australia melanoma is the 3rd most frequent malignant
tumor in women and 4th in men. In the USA there has
been noticed 120.5% increase in melanoma incidence in
the last two decades1–4. In the period 1968–1995 in Cro-
atia the incidence of melanoma was also in rise approxi-
mately 309% and melanoma mortality over 310%. Ac-
cording to Croatian National Cancer Registry there were
396 newly diagnosed melanoma patients in 2002 (209 fe-
males and 187 males), 414 in 2003 (222 females and 192
males) and 427 newly diagnosed melanoma patients in
2004 (237 females and 190 males). Also, in 2005 mela-
noma age-standardized (ASR-EU) incidence rate in
Croatia was 11.5/100000 (10.3/100000 for women and
13.4/100000 for men). Melanoma is the 11th most com-
mon malignancy in Croatia, and represents approxi-
mately 3% of all malignancies5.
Patients and Methods
In Croatia, National Referral Centre (NRC) for mela-
noma of the Ministry of Health and Welfare is situated in
the University hospital »Sestre milosrdnice« in Zagreb,
including the Department of Dermatology and Vene-
reology and the Department of Nuclear medicine and
Oncology. However, in everyday practice many other de-
partments within the hospital closely cooperate provid-
ing a multidisciplinary approach to melanoma patients.
Data on all melanoma patients registered at the Depart-
ment of Dermatology and Venereology in the period
2002–2007 were retrospectively analyzed according to
the Department records. However, it should be noted
that not all of the patients were diagnosed with mela-
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noma the same year they were registered at the NRC; re-
spectively some of them were diagnosed at some time
prior to registration in the NRC. Statistical analysis was
conducted using SPSS, version 12.
Results
During the 6-year period (2002–2007) there were 710
newly registered melanoma patients in the NRC, with
continuous rise in number each year, starting with 60 pa-
tients in 2002 up to 191 in the year 2007 (Table 1). There
were 396 (55.7%) female and 314 (44.3%) male patients
(Table 2).
Most of the patients were from Zagreb and the Coun-
ty of Zagreb which is not surprising since the NRC is sit-
uated in Zagreb, and it also is the most populated region
of Croatia with almost one million inhabitants. There
were also many patients from the Northern part of the
Adriatic coast namely County of Istria as well as from the
County of Sisak-Moslavina, County of Karlovac, County
of Split-Dalmatia and County of Slavonski Brod-Posa-
vina and all other parts of the country.
Age distribution at the time of diagnosis is shown in
the Figure 1. There were 3 patients (0.4%) in the age
group 0–9 years, 6 patients (0.9%) in the age group
10–19, 41 patients (5.8%) in the age group 20–29, 84 pa-
tients (11.9%) in the age group 30–39, 144 patients
(20.5%) in the age group 40–49, 172 patients (24.5%) in
the age group 50–59, 153 patients (21.8%) in the age
group 60–69, 82 patients (11.7%) in the age group 70–79,
and 18 patients (2.6%) in the age group 80 years and
older. Among 710 patients 6 were aged less than 18 and
in 5 of them melanoma developed de novo, while in one of
them melanoma developed within the pre-existing
dysplastic congenital nevus. Also, out of 710 melanoma
patients 23 (3.2%) were diagnosed with multiple primary
melanomas; one patient had 4 melanomas, two patients
had 3 melanomas, and 20 patients had 2 melanomas.
Distribution according to tumor localization on the
body showed that melanoma occurred most commonly on
trunk, than on the lower extremities and other sites (Fig-
ure 2). However, a significant difference in melanoma lo-
calization between men and women was noticed (Figure
3). In men the most common site of melanoma was trunk
namely on the back (40.8%) and in women the most com-
mon site of melanoma was on lower extremities (33.2%).
According to the histopathology there were 255 (59.6%)
superficial spreading melanomas (SSM), 120 (28%) nod-
ular melanomas (NM), 31 (7.2%) lentigo maligna mela-
nomas (LMM), and 13 (3.0%) acrolentiginous melanomas
(ALM). There were also 5 (1.2%) amelanotic melanomas
and approximately 1% of patients with diagnosed meta-
static melanoma of unknown primary tumor (Figure 4).
In both, men and women, the most common type of mela-
noma was SSM, however there was a significant differ-
ence in the portion of NM in the total number of mela-
noma among men and women, indicating that NM is
























Fig. 1. Age distribution of melanoma patients.
TABLE 1
NUMBER OF REGISTERED MELANOMA PATIENTS IN THE CROATIAN REFERRAL CENTRE (2002–2007)
Year of registration 2002 2003 2004 2005 2006 2007
N 60 100 121 116 122 191
TABLE 2
GENDER DISTRIBUTION OF MELANOMA PATIENTS REGISTERED


















































































Fig. 3. Localization of melanoma in female and male patients.
more common in men (Figures 4 and 5). In women 64.8%
were SSM, 22.4% NM, 6.8% LMM, 4.0% ALM, 1.2%
amelanotic melanoma and 0.4% metastatic melanoma of
unknown primary tumor. In men results were: 52.2%
SSM, 36.0% NM, 7.9% LMM and 1.7% ALM, 1.1% ame-
lanotic melanoma and 1.1% metastatic melanoma of un-
known primary tumor.
The tumor thickness according to the Breslow classi-
fication (Br I = 0–0.75 mm, Br II= 0.76–1.50 mm, Br III
= 1.51–4.0 mm, Br IV  4 mm) in analyzed melanoma pa-
tients is shown in Figures 6 and 7. There were 150
(27.1%) melanomas Breslow I, 152 (27.5%) Breslow II,
169 (30.6%) Breslow III, and 82 (14.8%) Breslow IV. How-
ever, a significant difference in the portion of lower
Breslow melanoma stages was noticed between female
and male patients. In women there were 98 (30.7%)
Breslow I stage, 92 (28.8%) Breslow II, 92 (28.8%) Bres-
low III, and 37 (11.6%) Breslow IV. In men the results
were as follows: 52 (22.2%) were Breslow I stage, 60
(25.6%) Breslow II, 77 (32.9%) Breslow III, and 45 (19.2%)
Breslow IV.
The mean tumor thickness for the total number (710)
of analyzed melanoma patients was 2.24 mm, with a lit-
tle variation per year in the 6-year-period (2002–2007)
(Table 3). Regarding the origin of melanoma, the ana-
mnestic data was available for 428 patients. There were
73 (17.1%) newly appearing (de novo) melanomas, 85
(19.9%) from congenital nevus, 246 (57.5%) from pre-ex-
isting acquired dysplastic nevus, and 24 (5.6%) from
lentigo maligna (Table 4).
Discussion
Epidemiological data indicates that melanoma inci-
dence is in constant rise throughout the world.
Numerous studies have identified risk factors for the
development of melanoma. The major factors include ex-
cessive sun exposure, number of melanocytic nevi, cuta-
neous phenotype, and family and personal history of mel-
anoma. UV radiation from sunlight appears to be the
principle environmental factor responsible for melanoma
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Fig. 5. Distribution of the various types of melanoma




































































Fig. 7. Tumor thickness by Breslow for female and
male melanoma patients.
TABLE 3
TUMOR THICKNESS BY YEAR OF REGISTRATION
Year of registration 2002 2003 2004 2005 2006 2007 2002–2007
Tumor thickness (mm) 2.21 2.21 2.24 2.32 2.49 1.77 2.24
TABLE 4
THE ORIGIN OF MELANOMA
Origin of melanoma N %
De novo 73 17
Acquired nevus 246 57.5
Congenital nevus 85 19.9
Lentigo maligna 24 5.6
development. This has been supported by studies which
have demonstrated an inverse relationship between lati-
tude and melanoma incidence6–8.
Melanoma is uncommon in darkly-skinned people; in
the United States, the incidence among blacks is only
1/10 that among whites9. Melanoma in blacks and Asians
most often occurs at parts of the body which are not sun
exposed, such as acral sites (nail beds and soles)10. Dur-
ing the past century, changes in clothing styles, recre-
ational activities, chronic occupational solar exposure,
longevity, and other aspects of lifestyle have resulted in
increased exposure to sunlight11. The incidence of mela-
noma increases with age, and it mostly occurs between
30–70 years of age. However, melanoma is one of the
most common cancers in young adults12. In our study
most of the patients (more than 65%) were aged between
40 and 70 years with the age peak 50–59 years at the
time of diagnose. Unlike the much more common skin
cancers such as basal cell carcinoma and spinalioma,
which are associated with cumulative UV radiation, mel-
anomas are associated with intense intermittent expo-
sure to UV radiation13–16. Thus, melanoma occurs com-
monly on intermittently sun exposed body sites, such as
the back in men and lower extremities in women12. The
same anatomical distribution was noticed in our group of
patients, too. On the other hand, it is well known that
LMM, a subtype associated with cumulative sun expo-
sure, frequently occurs on the head and neck in older
people17. Even though it is one the most aggressive ma-
lignant tumors in humans, melanoma is curable if de-
tected early and appropriately surgically excised. The
prognosis of melanoma is related to tumor thickness.
Various studies have shown that in recent years the rise
in the incidence of melanoma in the Western world is
mainly attributable to thin melanomas, while the num-
ber of intermediate and thick melanomas was stable18.
Unfortunately, the results of our study showed that in
one third of patients melanoma is diagnosed at Breslow
stage III (tumor thickness 1.5–4.00 mm), with thick mel-
anomas significantly more frequent in male patients. Tu-
mor thickness approaching 4 mm presents a high risk of
metastasis, and a diagnosis of metastatic melanoma car-
ries with it an abysmal median survival of 6–9 months19.
The major subtypes of melanoma include SSM, NM,
LMM, and ALM. SSM is the most common type of mela-
noma and it represents 60–70% of all melanomas. NM
are the second most common form of melanoma and usu-
ally have bad prognosis because frequently diagnosed at
a thicker stage, while LMM usually has better prognosis
because of very long radial growth phase. In our study in
both, men and women, the most common type of mela-
noma was SSM, however there was a significant differ-
ence in the portion of NM in the total number of mela-
noma among men and women, indicating that NM is
more common in men.
There are various data regarding the origin of mela-
noma. According to some authors in 50–60% of patients
melanoma develops on previously unchanged skin (de
novo), while only a smaller part of melanomas develop
within the previously existing melanocytic nevus, of which
most are congenital nevi. Approximately 25–30% of mel-
anomas show histological signs of pre-existing melano-
cytic nevus and, of these nevi, 40% are congenital and
60% acquired dysplastic nevi20,21. On the contrary, in our
study most of the tumors developed within the pre-exist-
ing acquired dysplastic nevi. However, these results
should be interpreted carefully since they are the ob-
tained from the patients’ anamnestic data which may not
always be accurate.
Conclusion
The incidence of melanoma, one of the most aggres-
sive skin tumors, is rising rapidly all over the world22.
Various studies have shown that in recent years the rise
in the incidence of melanoma in the Western world is
mainly attributable to thin melanomas. However, in
Croatia there is still a trend of diagnose at relatively
thick melanoma, especially in male population. Although
there have been considerable advances and breakthroughs
in the treatment of melanoma, the therapy for meta-
static disease is limited. Until the time comes when mela-
noma is curable at all stages, our efforts should be fo-
cused on risk reduction by limiting UV radiation expo-
sure and timely recognition23. Protection from the UV
radiation is most effective when begun in early child-
hood. Primary prevention of melanoma and early detec-
tion are essential to reduce incidence and melanoma
mortality in the future years.
R E F E R E N C E S
1. MARKS R, Clin Exp Dermatol, 25 (2000) 459. — 2. DIEPGEN TL,
MAHLER V, Br J Dermatol, 146 (2002) 1. — 3. THOMPSON JF, SCOL-
YER RA, KEFFORD RF, Lancet, 365 (2005) 687. — 4. BEVONA C, SO-
BER AJ, Dermatol Clin, 20 (2003) 589. — 5. Croatian National Institute
for Public Health, Croatian National Cancer Registry. Cancer incidence
in Croatia, Bulletins No 1–30 (Croatian National Institute for Public
Health, Zagreb, 1983–2007). — 6. LANGLEY RB, SOBER AJ, Cancer In-
vest, 15 (1997) 561. — 7. MOAN J, POROJNICU AC, DAHLBACK A, Adv
Exp Med Biol, 624 (2008) 104. — 8. LONGSTRETH J, Cancer Metastasis
Rev, 4 (1988) 321. — 9. PARKIN DM, MUIR CS, WHELAN SL, GAO YT,
FERLAY J, POWELL J, Cancer incidence in five continents. Vol. 6 (Inter-
national Agency for Research on Cancer, Lyon, 1992). — 10. KOH HK, N
Eng J Med, 325 (1992) 171. — 11. FREEDBERG IM, EISEN AZ, WOLFF
K, AUSTEN KF, GOLDSMITH LA, KATZ SI, Fitzpatrick’s Dermatology
in General Medicine (McGraw-Hill, New York, 2003). — 12. GILCHREST
BA, ELLER MS, GELLER AC, YAAR M, N Eng J Med, 340 (1999) 1341.
— 13. RASS K, REICHRATH J, Adv Med Biol, 624 (2008) 162. — 14.
GALLAGHER RP, MA B, McLEAN DI, J Am Acad Dermatol, 23 (1990)
423. — 15. BENTHAM G, AASE A, Int J Epidemiol, 25 (1996) 1132. —
16. WESTERDAHL J, OLSSON H, INGVAR C, BRANDT L, JONSSON
PE, MOLLER T, Anticanser Res, 12 (1992) 1539. — 17. LACHIEWICZ
AM, BERWICK M, WIGGINS CL, THOMAS NE, J Invest Dermatol, 128
(2008) 243. — 18. LIPSKER D, ENGEL B, CRIBIER M, VELTEN M, HE-
DELIN G, Br J Dermatol, 157 (2007) 338. — 19. CHIN L, GARRAWAY
LA, FISHER DE, Genes Dev, 16 (2006) 2149. — 20. BRAUN-FALCO O,
PLEWIG G, WOLFF HH, BURGDORF WHC, Dermatology (Springer-
M. Buljan et al.: Epidemiology of Melanoma, Coll. Antropol. 32 (2008) Suppl. 2: 47–51
50
-Verlag, Berlin, 2000). — 21. STERRY W, PAUS R, BURGDORF W, Der-
matology (Georg Thieme Verlag, Stuttgart, 2006). — 22. [ITUM M, BU-
LJAN M, O@ANI] BULI] S, [IMI] D, Coll Antropol, 31 (2007) 13. — 23.
SJEROBABSKI MASNEC I, VODA K, [ITUM M, Coll Antropol, 31
(2007) 97.
M. Buljan
Department of Dermatology and Venereology, University Hospital »Sestre milosrdnice«, Vinogradska cesta 29,
10000 Zagreb, Croatia
e-mail: buljan.marija@gmail.com
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S A @ E T A K
Melanom pripada me|u najagresivnije maligne tumore ko`e i sluznica. Posljednjih desetlje}a kontinuiran porast
incidencije melanoma bilje`i se gotovo u ~itavom svijetu. Diljem svijeta incidencija melanoma varira, a najvi{a je u
Novom Zelandu i Australiji. Unazad 40ak godina u Hrvatskoj je zabilje`en porast incidencije tog tumora vi{e od 300%.
U~estalost pojavljivanja melanoma gotovo je jednaka u `ena i mu{karaca. Prema lokalizaciji, melanom se sve ~e{}e
pojavljuje na ko`i trupa, a zatim na donjim ekstremitetima, dok je u~estalost pojave melanoma na ko`i glave i vrata
ostala ista. Posljednjih desetlje}a melanom se sve ~e{}e dijagnosticira u mla|ih osoba u dobi od 25–40 godina, a rijetko u
djetinjstvu. S druge strane, produljeno pre`ivljenje bolesnika s melanomom u zapadno-europskim zemljama posljednjih
godina pripisuje se ranom prepoznavanju melanoma. Na `alost, u Hrvatskoj je, u odnosu na te zemlje, mortalitet vi{i
iako je incidencija jednaka ili ni`a nego u pojedinim zapadno-europskim zemljama. U radu autori izla`u epidemiolo{ke
podatke o malignom melanomu u Hrvatskom Referentnom centru za melanom KB »Sestre milosrdnice« u Zagrebu, za
6-godi{nje razdoblje (2002.–2007. g.).
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